Can statins damage the liver?

Statins may affect liver function, but the risk of liver injury is low. Most individuals who take statins as prescribed do not develop abnormal liver function. These medications are primarily used to regulate blood lipid levels and stabilize atherosclerotic plaques in blood vessels. Routine monitoring of liver function during treatment is sufficient. If symptoms such as fatigue or loss of appetite occur, prompt medical evaluation is recommended.

Statins are metabolized by the liver; therefore, long-term use slightly increases the liver’s metabolic burden. A small proportion of patients may experience transient elevations in liver enzyme levels, which typically resolve spontaneously without intervention. Patients with dyslipidemia, coronary artery disease, or other related conditions must adhere consistently to prescribed statin therapy to control their condition—abrupt discontinuation should be avoided, as it may trigger a rebound increase in lipid levels and exacerbate vascular disease.

For patients who develop persistent elevation of liver enzymes while on statins, dosage adjustment or switching to an alternative statin may be considered, along with adjunctive hepatoprotective therapy to support liver function. Regular screening of liver function tests and lipid profiles—and timely modification of the treatment regimen based on clinical and laboratory findings—can effectively prevent statin-associated liver injury and ensure safe medication use.

In daily life, maintaining a low-fat diet, adhering to regular sleep schedules (avoiding late-night activities), abstaining from alcohol, and engaging in moderate physical exercise help sustain healthy metabolic function and reduce the liver’s metabolic workload—thereby mitigating potential adverse effects associated with statin therapy.